Early Detection of Cardiac Damage With Heart Fatty Acid-Binding Protein After Cardiac Operations Ken Suzuki, Yoshiki Sawa, Keishi Kadoba, Toshiki Takahashi,

Slides:

Advertisements

Similar presentations

Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting Bülent Tünerir, MD, Ömer Çolak, MD,

Advertisements

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations Zhong-Kai Wu, MD, PhD, Jari Laurikka, MD, PhD, Antti Saraste, MD, PhD, Ville.

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting Y.John Gu, Massimo A Mariani, Willem.

Revascularization of severe hibernating myocardium in the beating heart: early hemodynamic and metabolic features Evasio Pasini, MD, Gianna Ferrari,

Can Fontan Conversion for Patients Without Late Fontan Complications be Justified? Akihiko Higashida, MD, Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Masatoshi.

Peter K. Smith, MD, Michel Carrier, MD, John C

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study Song Wan, MD, PhD, Jean-Louis.

Assessment of Continuous Cold Blood Cardioplegia in Coronary Artery Bypass Grafting Yves A.G Louagie, Emmanuel Gonzalez, Jacques Jamart, Brigitte Malhomme,

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Minimally Invasive Coronary Artery Bypass Grafting Using the Right Gastroepiploic Artery Sari Voutilainen, Kalervo Verkkala, Antero Järvinen, Markku.

Randomized Comparison Between Normothermic and Hypothermic Cardiopulmonary Bypass in Pediatric Open-Heart Surgery Massimo Caputo, MD, Simon Bays, Chris.

Michael Frenken, MD, Arno Krian, MD The Annals of Thoracic Surgery

Myocardial injury in coronary artery bypass grafting: On-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin.

Penehyclidine hydrochloride preserves the intestinal barrier function in patients undergoing cardiopulmonary bypass Ying-jie Sun, PhD, Dan-dan Song,

Cardiac troponin I release after open heart surgery: a marker of myocardial protection? Emmanuelle Vermes, MD, Martine Mesguich, MD, Rémi Houel, MD, Céline.

Early Diagnosis of Perioperative Myocardial Infarction After Coronary Bypass Grafting: A Study Using Biomarkers and Cardiac Magnetic Resonance Imaging

Comparison of troponin-I and troponin-T after pediatric cardiovascular operation Franz F Immer, MD, Franco P Stocker, MD, Andrea M Seiler, MD, Jean-Pierre.

François Dagenais, MD, L.Conrad Pelletier, MD, Michel Carrier, MD

Coronary artery bypass grafting using the gastroepiploic artery in 1,000 patients Hitoshi Hirose, MD, Atushi Amano, MD, Shuichirou Takanashi, MD, Akihito.

Severe ischemic early liver injury after cardiac surgery

How safe is the port access technique in minimally invasive coronary artery bypass grafting? Selami Dogan, MD, Kai Graubitz, MD, Tayfun Aybek, MD, Mohammad.

Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective coronary artery bypass.

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve.

Effect of low-dose ketamine on inflammatory response in off-pump coronary artery bypass graft surgery J.E. Cho, J.K. Shim, Y.S. Choi, D.H. Kim, S.W.

Efficient gene transfer method into the whole heart through the coronary artery with hemagglutinating virus of Japan liposome Yoshiki Sawa, MDa, Keishi.

One-stage coronary and abdominal aortic operation with or without cardiopulmonary bypass: early and midterm follow-up Raimondo Ascione, MD, Gabriele.

The Contribution of Na/H Exchange to Ischemia-Reperfusion Injury After Hypothermic Cardioplegic Arrest Takashi Yamauchi, MD, Hajime Ichikawa, MD, Yoshiki.

Hannu J Penttilä, MD, Martti V

Hannu J Penttilä, MD, Martti V

Role of myocardial temperature measurement in monitoring the adequacy of myocardial protection during cardiac surgery Joseph A Dearani, MD, Trevor C.

Continuous cold blood cardioplegia improves myocardial protection: a prospective randomized study Yves A.G Louagie, MD, PhD, Jacques Jamart, MD, Manuel.

Terry Shih, MD, Justin B. Dimick, MD, MPH

Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery P.-G. Chassot, A. Delabays, D.R. Spahn

Heart-Type Fatty Acid Binding Protein and Ischemia-Modified Albumin for Detection of Myocardial Infarction After Coronary Artery Bypass Graft Surgery

Michel Carrier, MD, Michel Pellerin, MD, Louis P Perrault, MD, PhD, B

F. Fontan, MDa, F. Madonna, MDa, D. C. Naftel, PhDb, J. W

Editorial Board, January 2010

Ischemic preconditioning does not improve myocardial preservation during off-pump multivessel coronary operation Hannu J Penttilä, MD, Martti V.K Lepojärvi,

Nilanjan Chaudhuri, Mark St.J Hickey The Annals of Thoracic Surgery

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

Spool-Like Stent for the Open Sternum After Cardiac Operations

Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation Yoshitaka Hayashi, MD, Yoshiki Sawa, MD, Motonobu Nishimura,

Retrograde versus antegrade crystalloid cardioplegia in coronary surgery: value of troponin-I measurement Ulrich Franke, MD, Thorsten Wahlers, MD, Tina.

Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard.

Mudassir I Dar, Timothy Gillott, Franco Ciulli, MD, Graham J Cooper

Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting Zhong-Kai Wu, MD, Matti R Tarkka,

Evaluation of heart fatty acid–binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery Tomomi Hasegawa,

Vascular Endothelial Growth Factor Attenuates Myocardial Ischemia-Reperfusion Injury Zhengyu Luo, Maurizio Diaco, Toyoaki Murohara, Napoleone Ferrara,

E. -H. Lee, H. -M. Lee, C. -H. Chung, J. -H. Chin, D. -K. Choi, H. -J

Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting Bülent Tünerir, MD, Ömer Çolak, MD,

Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass Sudip Ghosh, MD, Manuel Galiñanes,

Valvular heart operation is an independent risk factor for acute renal failure Antony D Grayson, Magdy Khater, FRCA, Mark Jackson, PhD, Mark A Fox, FRCA

Preoperative Intraaortic Balloon Pump Enhances Cardiac Performance and Improves the Outcome of Redo CABG Jan T. Christenson, MD, PhD, Pierre Badel, MD,

Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial Akira Sezai,

Levels of Troponin I and Cardiac Enzymes After Reinfusion of Shed Blood in Coronary Operations Ruggero De Paulis, MD, Luisa Colagrande, MD, Francesco.

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Markers of myocardial ischemia after minimally invasive and conventional coronary operation Erich Kilger, MD, Bodo Pichler, MD, Florian Weis, MD, Alwin.

Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.

Determinants and Prognosis of Myocardial Damage After Coronary Artery Bypass Grafting Francesco Onorati, MD, Marisa De Feo, MD, PhD, Pasquale Mastroroberto,

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations Zhong-Kai Wu, MD, PhD, Jari Laurikka, MD, PhD, Antti Saraste, MD, PhD, Ville.

Serum S100β release after coronary artery bypass grafting: roller versus centrifugal pump Saeed Ashraf, Kausik Bhattacharya, Sunny Zacharias, Pradeep.

Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and.

Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery Yoshiya Toyoda, MD, Masahiro Yamaguchi,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Roderick W Landymore, MD, Alexander J Bayes, MD, J

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Arch-first technique for aortic arch aneurysm repair through median sternotomy Motonobu Nishimura, MD, Shigeaki Ohtake, MD, Yoshiki Sawa, MD, Toshiki.

Reduced Cytokines Release and Myocardial Damage in Coronary Artery Bypass Patients Due to L-Arginine Cardioplegia Supplementation Luisa Colagrande, MD,

Presentation transcript:

Early Detection of Cardiac Damage With Heart Fatty Acid-Binding Protein After Cardiac Operations Ken Suzuki, Yoshiki Sawa, Keishi Kadoba, Toshiki Takahashi, Hajime Ichikawa, Koji Kagisaki, Toshihiro Ohata, Hikaru Matsuda The Annals of Thoracic Surgery Volume 65, Issue 1, Pages 54-58 (January 1998) DOI: 10.1016/S0003-4975(97)01260-5

Fig. 1 Time course of serum human heart fatty acid-binding protein (HH-FABP), creatine kinase MB isoform (CK-MB), and troponin-T (TnT) levels after reperfusion in 20 patients undergoing coronary artery bypass grafting (shown as mean ± standard error of the mean). (pre = preoperation.) The Annals of Thoracic Surgery 1998 65, 54-58DOI: (10.1016/S0003-4975(97)01260-5)

Fig. 2 Time needed to reach the maximum serum levels of indicators for myocardial damage. Data are shown as mean ± standard error of the mean (n = 20). (CK-MB = creatine kinase MB isoform; HH-FABP = human heart fatty acid-binding protein; TnT = troponin-T; ∗p < 0.0001.) The Annals of Thoracic Surgery 1998 65, 54-58DOI: (10.1016/S0003-4975(97)01260-5)

Fig. 3 Serum human heart fatty acid-binding protein (HH-FABP) levels immediately after reperfusion plotted against maximum (max) serum HH-FABP levels. The Annals of Thoracic Surgery 1998 65, 54-58DOI: (10.1016/S0003-4975(97)01260-5)

Fig. 4 (A) Maximum (max) serum creatine kinase MB isoform (CK-MB) levels plotted against maximum serum human heart fatty acid-binding protein (HH-FABP) levels. (B) Maximum serum troponin-T (TnT) levels plotted against maximum HH-FABP levels. The Annals of Thoracic Surgery 1998 65, 54-58DOI: (10.1016/S0003-4975(97)01260-5)

Fig. 5 (A) Aortic cross-clamp time (AXC) and (B) maximum (max) dose of catecholamine administration after cardiopulmonary bypass plotted against maximum serum human heart fatty acid-binding protein (HH-FABP) levels. The Annals of Thoracic Surgery 1998 65, 54-58DOI: (10.1016/S0003-4975(97)01260-5)